34,564 Shares in Envista Holdings Corporation $NVST Purchased by Odyssean LLC

Odyssean LLC purchased a new stake in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 34,564 shares of the company’s stock, valued at approximately $911,000.

Several other hedge funds have also bought and sold shares of the business. Parallel Advisors LLC grew its holdings in Envista by 13.1% in the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after purchasing an additional 367 shares during the period. Bank of Montreal Can lifted its holdings in shares of Envista by 1.4% during the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock valued at $568,000 after purchasing an additional 372 shares during the last quarter. Sepio Capital LP boosted its position in shares of Envista by 1.2% in the 4th quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after purchasing an additional 374 shares in the last quarter. Deutsche Bank AG boosted its position in shares of Envista by 2.9% in the 4th quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after purchasing an additional 484 shares in the last quarter. Finally, State of Michigan Retirement System grew its stake in shares of Envista by 1.5% in the 1st quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock worth $1,001,000 after buying an additional 600 shares during the last quarter.

Insider Buying and Selling at Envista

In other news, SVP Mischa Reis sold 8,000 shares of the business’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the transaction, the senior vice president owned 27,321 shares in the company, valued at $751,327.50. The trade was a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by corporate insiders.

Envista Price Performance

Shares of NVST opened at $27.76 on Thursday. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42. The company has a market capitalization of $4.46 billion, a P/E ratio of 47.86, a price-to-earnings-growth ratio of 1.31 and a beta of 0.86. The firm has a 50 day moving average of $27.06 and a 200 day moving average of $26.38. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a return on equity of 7.88% and a net margin of 3.33%.The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. During the same period in the prior year, the firm posted $0.26 EPS. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities research analysts anticipate that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on NVST. Weiss Ratings raised Envista from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 6th. Barclays dropped their target price on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Zacks Research raised Envista from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. Robert W. Baird set a $34.00 price target on Envista in a report on Thursday, August 6th. Finally, Evercore reaffirmed an “outperform” rating and issued a $33.00 price target on shares of Envista in a research report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat, Envista has an average rating of “Moderate Buy” and an average target price of $29.31.

View Our Latest Report on NVST

Envista Company Profile

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Featured Articles

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.